dysautonomia


Also found in: Dictionary, Encyclopedia, Wikipedia.

dysautonomia

 [dis″aw-to-no´me-ah]
malfunction of the autonomic nervous system.
familial dysautonomia Riley-Day syndrome.

dys·au·to·no·mi·a

(dis'aw-tō-nō'mē-ă),
Abnormal functioning of the autonomic nervous system.
[dys- + G. autonomia, self-government]

IKBKAP

A gene on chromosome 9q31 that encodes a putative scaffold protein which may assemble active IKK-MAP3K14 complexes and act as subunit of the RNA polymerase II elongator complex, a histone acetyltransferase component of the RNA polymerase II (Pol II) holoenzyme involved in transcriptional elongation. The elongator complex may play a role in chromatin remodelling; it may be involved in acetylation of histone H3 and possibly also H4.

Molecular pathology
Defects in IKBKAP cause familial dysautonomia, also known as hereditary sensory and autonomic neuropathy type 3, or Riley-Day syndrome.

dysautonomia

Neurology Any condition characterized by sympathetic or parasympathetic derangements; autonomic hypofunction or failure is most often caused by drugs and disease-associated polyneuropathies–eg, DM and amyloidosis, but may be idiopathic Classifications Primary dysautonomia system, sanctioned by the American Academy of Neurology; Goldstein classification. See Familial dysautonomia aka Riley-Day syndrome.

dys·au·to·no·mi·a

(dis'aw-tō-nō'mē-ă)
Abnormal functioning of the autonomic nervous system.
[dys- + G. autonomia, self-government]

dys·au·to·no·mi·a

(dis'aw-tō-nō'mē-ă)
Abnormal functioning of autonomic nervous system.
[dys- + G. autonomia, self-government]

Patient discussion about dysautonomia

Q. What is dysautonomia? My friend has dysautonomia. What does it mean? What are the symptoms? Is it curable?

A. Dysautonomia is any disease or malfunction of the autonomic nervous system. The symptoms of dysautonomia conditions are usually “invisible” to the untrained eye. The child can appear to be as healthy as other children. The manifestations are occurring internally, and although the symptoms are often are not visible on the outside. Symptoms can be unpredictable, may come and go, appear in any combination, and may vary in severity).There is no cure for dysautonomia. There are medications to assist in stabilization, but are often needed on a long-term basis.

More discussions about dysautonomia
References in periodicals archive ?
Cardiovascular dysautonomia in Parkinson disease: From pathophysiology to pathogenesis.
Treatment must address often-found comorbid medical conditions, such as irritable bowel syndrome, other gastrointestinal conditions, temporomandibular dysfunction, fatigue, fibromyalgia, and dysautonomia. Obviously specific attention must be paid to JHS/hEDS, which responds relatively well to physical treatments, including aerobic exercise, and particularly well to expert physiotherapy.
The following are reported factors leading to poorer QoL in DLB patients: independence in instrumental ADL, whether the patient is living with the caregiver, the presence of depression, apathy, delusion, and dysautonomia.
Reichmann, "Cardiovascular dysautonomia in de novo Parkinson's disease," Journal of the Neurological Sciences, vol.
Kauffmann, "Ipilimumab-induced Guillain-Barre syndrome presenting as dysautonomia: an unusual presentation of a rare complication of immunotherapy," Journal of Immunotherapy, vol.
Many efforts have been made to elucidate the neuronal mechanisms underlying dysautonomia of the cardiovascular system such as hypertension [1].
The (http://www.mayo.edu/research/departments-divisions/department-neurology/programs/autonomic-nerve-disorders) Mayo Clinic gives examples of autonomic disorders - a group of conditions that is also known as dysautonomia - such as orthostatic hypotension, in which blood pressure drops upon standing; erectile dysfunction; and neurogenic bowel, which can occur after a spinal injury and affects a person's ability to control their bowel movements.
In the context of post stroke cardiac dysautonomia, this patient presented impaired adaptability to effort.
The source of dysautonomia can often be determined by clinical context, coexisting neurologic abnormalities, targeted testing of the autonomic nervous system, and neuroimaging.
Cardiovascular reactivity score for the assessment of dysautonomia in familial Mediterranean fever.
One pediatric patient had also failed standard dysautonomia treatments and was unsuccessfully treated with immunotherapy drugs.
Neuroleptic malignant syndrome (NMS) is an uncommon but potentially fatal idiosyncratic reaction to neuroleptics and characterized by a distinctive clinical syndrome of mental status change, rigidity, fever, and dysautonomia. Cotard's syndrome is characterized by the appearance of nihilistic delusions concerning one's own body or life.